8th ISAP Symposium
Developments in Pharmacokinetics and Pharmacodynamics (PK/PD):
optimizing efficacy and prevention of resistance
Nijmegen, The Netherlands, July 4th-6th, 2001


Ten Years After: Where is ISAP?

Click here to start

Table of Contents

Ten Years After: Where is ISAP?

Birth of ISAP

Name of Society

“Objects and Purposes of the Society”

“Objects and Purposes of the Society”

Pharmacodynamics before 1991

Pharmacodynamics in 2001

Pharmacodynamics in 2001

“Objects and Purposes of the Society”

Activities of ISAP

Topics of Symposia

Activities of ISAP

FDA-IDSA Guidelines (1992)

Points to Consider (1992)

NCCLS Documents (1991-92) 

FDA Moderization Act (1997) FDAMA

Developing Antimicrobial Drugs General Considerations (7/98)

PK/PD Parameters

Pharmacodynamics

PK/PD Applications

PK/PD Applications

PK/PD Applications

CPMP (European Regulatory): Points to Consider on PK and PD in the Development of Antibacterial Medicinal Products - 1999

CPMP (European Regulatory): Points to Consider on PK and PD in the Development of Antibacterial Medicinal Products - 1999

PK/PD Parameters with Beta-Lactams

PK/PD Parameters with Fluoroquinolones

PK/PD Parameters and Levofloxacin

PK/PD Parameters with Fluoroquinolones

Pharmacodynamics and Regulatory Organizations

Factors to Consider when Establishing Breakpoints (NCCLS)-M23 Document

PPT Slide

“Objects and Purposes of the Society”

Tasks for the Future

Ten Years After: Where is ISAP?

Author: William A. Craig 

Email: webmaster@isap.org

Home Page: http://www.isap.org/slides.htm

Important Note:

These slides are for information only. Do not make public use of them without autorization of the author and of the ISAP Webmaster 

Download presentation as PDF file